REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/21/2025
Back to search
Official data from USPTO
TAROPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
02/21/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/24/2002
Registration date
02/21/2006
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/26/2016
Last transaction
02/21/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/08/2003
First use in commerce
05/08/2003
Drawing code
1
Owner type
03
Owner location
Hawthorne, NY
Examiner
ESTRADA, LINDA
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Taro Pharmaceuticals U.S.A., Inc.
Representatives
Intellectual Property Dept. Sun Pharma
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
dermatological productspharmaceuticals for the treatment of dyschromiahyperpigmentationectoparasitesskin conditions such as psoriasisdermatitis and inflammationitching and blood vessel constriction
Publications
History of USPTO decisions and trademark events.
49 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/06/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/06/2017
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/26/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/26/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/26/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/26/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
02/18/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/12/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/12/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/12/2011
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
04/12/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/12/2011
PAPER RECEIVED
03/22/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
02/21/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
01/10/2006
ALIE
ASSIGNED TO LIE
01/06/2006
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/03/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/15/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2005
PAPER RECEIVED
11/30/2005
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/28/2005
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/28/2005
CNFR
FINAL REFUSAL MAILED
10/31/2005
CNFR
SU - FINAL REFUSAL - WRITTEN
10/31/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/06/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2005
PAPER RECEIVED
03/09/2005
CNRT
NON-FINAL ACTION MAILED
10/04/2004
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/01/2004
DOCK
ASSIGNED TO EXAMINER
09/30/2004
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/28/2004
EX2G
SOU EXTENSION 2 GRANTED
09/28/2004
CFIT
CASE FILE IN TICRS
09/13/2004
IUAF
USE AMENDMENT FILED
09/02/2004
EXT2
SOU EXTENSION 2 FILED
09/02/2004
PAPER RECEIVED
09/02/2004
PAPER RECEIVED
07/28/2004
EX1G
SOU EXTENSION 1 GRANTED
01/13/2004
EXT1
SOU EXTENSION 1 FILED
01/13/2004
PAPER RECEIVED
01/13/2004
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/09/2003
PUBO
PUBLISHED FOR OPPOSITION
06/17/2003
NPUB
NOTICE OF PUBLICATION
05/28/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/23/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2003
PAPER RECEIVED
03/27/2003
CNRT
NON-FINAL ACTION MAILED
02/25/2003
DOCK
ASSIGNED TO EXAMINER
02/20/2003
Continuous trademark protection
Get notified about every new filing that threatens TAROPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.